Macrophage-Derived Exosomes as Advanced Therapeutics for Inflammation: Current Progress and Future Perspectives

Yanjuan Song1, Jing Hu2, Chunlian Ma3,4,5

  • 1Graduate School, Wuhan Sports University, Wuhan, Hubei Province, People's Republic of China.

PubMed

Insights

Macrophage-derived exosomes (M-Exos) are key regulators of inflammation in diseases. This review explores their biogenesis, function, and therapeutic potential through engineering strategies for inflammation modulation.

Area of Science:

  • Biomedical Sciences
  • Cell Biology
  • Immunology

Background:

  • Inflammation significantly impacts disease development.
  • Macrophage-derived exosomes (M-Exos) modulate inflammatory responses in conditions like pain, hypertension, and diabetes.
  • The precise roles and targets of M-Exos in disease-related inflammation require further elucidation.

Purpose of the Study:

  • To review current knowledge on M-Exos biogenesis and their function in inflammation modulation.
  • To highlight strategies for functionalizing and engineering M-Exos for therapeutic applications.
  • To discuss perspectives and challenges in M-Exos-based inflammation modulation.

Main Methods:

  • Literature review of M-Exos biogenesis and function.
  • Analysis of M-Exos engineering strategies and therapeutic advancements.
  • Discussion of M-Exos mechanisms in disease through inflammation modulation.

Main Results:

  • M-Exos possess significant potential in modulating inflammation.
  • Engineering strategies offer promising avenues for therapeutic development.
  • Understanding M-Exos' role in disease pathogenesis is crucial.

Conclusions:

  • M-Exos are critical regulators of inflammation with therapeutic potential.
  • Advanced engineering techniques enhance M-Exos efficacy for treating inflammatory diseases.
  • Further research is needed to fully harness M-Exos for disease management.